Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/TECH
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

BIO-TECHNE Corp (TECH) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bio-Techne Corporation (TECH) trades at $72.31, down 0.17% on the day, with a mixed technical and fundamental backdrop. The stock shows a bullish moving average signal but neutral oscillators, while valuation ratios like P/E of 62.44 and P/S of 9.36 appear elevated. Recent Q2 2026 earnings beat expectations with EPS of $0.52 versus $0.519 expected, and the company declared a $0.08 dividend payable in August 2026. Revenue trends are stable, but net income margin declined to 14.97% in 2025 from 25.09% in 2023, indicating profitability pressure.
Outlook is cautiously optimistic amid a pending acquisition by Merck KGaA at $73.00 per share, near the current price. Risks include high valuation, earnings volatility, and shareholder litigation scrutiny. Analysts are split with 46% buy ratings but no sells, and a consensus target of $71.86 suggests limited upside. Institutional interest is strong, with BlackRock adding shares in Q2 2026.
Read full analysis

Key Stats

  • Market Cap
    $11.34B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $72.48
  • 52W Low
    $43.31
  • Typical Hold Time
    -
  • Enterprise Value
    $11.36B
  • Div Yield
    0.44%
  • Trading Activity
    -
$72.28
52W Low: $43.31
15 May 2026
52W High: $72.48
19 Aug 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.48, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Most Recent News

Content is generated by Aura AI

Bitmine nears 5% ETH supply goal with $15.7B crypto holdings, driving strong Q3 gains and staking over 5M ETH.

Bitmine Immersion Technologies has accumulated 4.9% of the total Ethereum supply, holding $15.7 billion in crypto assets including 5.93 million ETH. The company has achieved 97% of its goal to acquire 5% of all ETH in just 15 months, contributing to ...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
Bitmine nears 5% ETH supply goal with $15.7B crypto holdings, driving strong Q3 gains and staking over 5M ETH.

US sanctions Xinbi Guarantee, a Chinese-linked scam platform laundering $52M in crypto from Americans

The US Attorney for the District of Columbia announced sanctions against Xinbi Guarantee, an online platform used by Chinese cybercriminals to facilitate scams targeting Americans, including fraudulent cryptocurrency investments. Authorities restrain...

Market News
4 hours ago
Fox Business
Bearish
news icon
US sanctions Xinbi Guarantee, a Chinese-linked scam platform laundering $52M in crypto from Americans

Jim Cramer favors Morgan Stanley over fintechs, praising its steady growth and $10T client assets milestone.

Jim Cramer expressed skepticism about the wave of new fintech and blockchain IPOs, describing many as similar and hard to differentiate. Instead, he highlighted Morgan Stanley as a strong, quietly executing incumbent that recently surpassed $10 trill...

Market News
4 hours ago
24/7 Wall Street
Bullish
news icon
Jim Cramer favors Morgan Stanley over fintechs, praising its steady growth and $10T client assets milestone.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $11.34B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $72.48
  • 52W Low
    $43.31
  • Typical Hold Time
    -
  • Enterprise Value
    $11.36B
  • Div Yield
    0.44%
  • Trading Activity
    -
$72.28
52W Low: $43.31
15 May 2026
52W High: $72.48
19 Aug 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.48, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!